|
Young Investigator travel support for the 2016 through 2020 APS Annual Scientific Meetings
|
5R13AT009161-03
|
$5,000
|
$5,000
|
PRICE, THEODORE
|
AMERICAN PAIN SOCIETY
|
|
Yale Cancer Biology Training Grant
|
5T32CA193200-03
|
$229,769
|
$229,769
|
GLAZER, PETER
|
YALE UNIVERSITY
|
|
Wisconsin NCI Community Oncology Research Program (WiNCORP)
|
5UG1CA189956-05
|
$2,080,158
|
$2,080,158
|
ONITILO, ADEDAYO
|
MARSHFIELD CLINIC RESEARCH FOUNDATION
|
|
Wisconsin and New Jersey Alliance in Precision Experimental Therapeutics
|
5UM1CA186716-04
|
$500,917
|
$500,917
|
MEHNERT, JANICE
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
WDR5 as a Critical Co-Factor for MYC
|
5F31CA210429-03
|
$29,196
|
$29,196
|
FOSHAGE, AUDRA
|
VANDERBILT UNIVERSITY
|
|
Washington University Paul Calabresi K12 Career Development Award for Clinical Oncology
|
5K12CA167540-07
|
$810,000
|
$810,000
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
Washington University Cancer Genomics and Outcomes Research STRENGTH Program
|
5R25CA190190-04
|
$180,001
|
$180,001
|
GOVINDAN, RAMASWAMY
|
WASHINGTON UNIVERSITY
|
|
Vitamin D and HA Signaling in TNBC
|
5R01CA194500-04
|
$353,419
|
$353,419
|
WELSH, JOELLEN
|
STATE UNIVERSITY OF NEW YORK AT ALBANY
|
|
Vitamin D and Follicular Lymphoma
|
5R01CA214890-02
|
$615,082
|
$615,082
|
FRIEDBERG, JONATHAN
|
UNIVERSITY OF ROCHESTER
|
|
Viral priming and targeting NK cells against solid tumor malignancies
|
5R35CA197292-04
|
$796,220
|
$796,220
|
MILLER, JEFFREY
|
UNIVERSITY OF MINNESOTA
|
|
Viral oncoproteins: Revealing novel structural motifs to target tumor suppressors
|
5R01CA178932-05
|
$402,550
|
$402,550
|
O'SHEA, CLODAGH
|
SALK INSTITUTE FOR BIOLOGICAL STUDIES
|
|
Viral Modulation of Genetic Stability
|
5R01CA097093-15
|
$399,000
|
$399,000
|
WEITZMAN, MATTHEW
|
CHILDREN'S HOSP OF PHILADELPHIA
|
|
ViKTriY Early Clinical Trials Consortium (ECTC)
|
5UM1CA186689-04
|
$1,325,865
|
$1,325,865
|
LORUSSO, PATRICIA
|
YALE UNIVERSITY
|
|
VERSA: An Integrated, Multi-Endpoint Platform for Circulating Tumor Cell Analysis
|
5R01CA181648-05
|
$311,847
|
$311,847
|
LANG, JOSHUA
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
VCU Massey Cancer Center Minority Based NCI Community Oncology Research Program
|
5UG1CA189869-05
|
$1,196,666
|
$1,196,666
|
GEYER, CHARLES
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Variant identification for cancer genomics
|
1R15CA220059-01A1
|
$447,460
|
$447,460
|
GRIGORIEV, ANDREY
|
RUTGERS THE STATE UNIV OF NJ CAMDEN
|
|
Validation of Critical 1q21 Vulnerabilities in Multiple Myeloma
|
1R01CA222253-01
|
$381,997
|
$381,997
|
COLLA, SIMONA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer
|
5U01CA152662-08
|
$711,290
|
$711,290
|
MASSION, PIERRE
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
Validation of a Room-Temperature Storage Technique for Plasma/Serum Biospecimens
|
5R33CA204510-03
|
$338,767
|
$338,767
|
AKSAN, ALPTEKIN
|
UNIVERSITY OF MINNESOTA
|
|
Validating the eCyPA/CD147 signaling complex for myeloma therapy
|
5R01CA196783-04
|
$394,823
|
$394,823
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INST
|
|
UTX, MLL AND PATHOGENIC DEREGULATION OF HISTONE METHYLATION IN MULTIPLE MYELOMA
|
5R01CA180475-05
|
$347,390
|
$347,390
|
LICHT, JONATHAN
|
UNIVERSITY OF FLORIDA
|
|
Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care
|
5R01CA183962-04
|
$603,232
|
$603,232
|
HERNANDEZ-BOUSSARD, TINA
|
STANFORD UNIVERSITY
|
|
USP7 inhibitors for the treatment of multiple myeloma
|
5R01CA211681-02
|
$504,721
|
$504,721
|
BUHRLAGE, SARA
|
DANA-FARBER CANCER INST
|
|
USP22 Function in Advanced Prostate Cancer
|
5R01CA182569-04
|
$493,498
|
$493,498
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
USING RADIOMICS TO IMPACT RADIOTHERAPY TREATMENT PLANNING - Moonshot
|
261201800011C
|
$225,000
|
$225,000
|
N/A
|
HEALTHMYNE, INC.
|
|
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer
|
5U01CA199216-04
|
$623,508
|
$623,508
|
JACKSON, PETER
|
STANFORD UNIVERSITY
|
|
Using extracellular metabolites to understand and revert protumoral effects of Tumor-Associated Macrophages
|
5R00CA191021-04
|
$249,000
|
$249,000
|
CARMONA-FONTAINE, CARLOS
|
NEW YORK UNIVERSITY
|
|
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy
|
5F30CA206424-03
|
$38,124
|
$38,124
|
CHEN, MARK
|
DUKE UNIVERSITY
|
|
Using Clinical Pharmacology Principles to Develop New Anticancer Therapies
|
ZIC SC 006537
|
$732,342
|
$732,342
|
Figg, William
|
CCR (NCI)
|
|
USDA/NCI DCP FY 2018 IAA - ACN 18003-001-00000 - USDA - DIET-GENETIC INTERACTIONS - EXAMINE ABSORPTION OF ISOTHIOCYANATES & CAROTENOIDS DERIVED FROM FREEZE-DRIED BROCCOLI
|
ACN 18003-00
|
$181,500
|
$181,500
|
N/A
|
UNITED STATES DEPT OF AGRICULT
|
|
USDA - NUTRIENT INTERACTION - IMMUNE-PREVENTIVE EFFECTS OF I3C/DIM IN CITROBACTER RODENTIUM-INFECTED MOUSE MODEL
|
ACN18001-001
|
$65,000
|
$65,000
|
-, -
|
UNITED STATES DEPT OF AGRICULT
|
|
USAG PYMT
|
ACO17004-001
|
$9,041,735
|
$9,041,735
|
-, -
|
UNITED STATES DEPARTMENT OF THE ARMY
|
|
Urologic Oncology Research Training Grant
|
5T32CA082088-19
|
$302,547
|
$302,547
|
CARVER, BRETT
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
UPON PROVISIONING THE BASE PLATFORM FOR THE PILOT AND PROVIDING ACCESS FOR UP TO 125 NCI USERS -- CATALOG : NA
|
271201800020I
|
$1,250,000
|
$1,250,000
|
N/A
|
PALANTIR TECHNOLOGIES INC.
|
|
Unraveling glutamine metabolism in gliomas by PET imaging and biochemical methods
|
5K08CA181475-06
|
$140,454
|
$140,454
|
VENNETI, SRIRAM
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
|
Unphosphorylated STAT recruits HP1 for gene repression
|
5R03CA212727-02
|
$77,500
|
$77,500
|
LI, WILLIS
|
UNIVERSITY OF CALIFORNIA, SAN DIEGO
|
|
Unmet needs for specific subsets of EGFR mutated lung cancer
|
1R37CA218707-01A1
|
$409,171
|
$409,171
|
COSTA, DANIEL
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
|
Unlocking the Potential of PI3K Inhibition in CLL
|
5R01CA213442-02
|
$596,117
|
$596,117
|
BROWN, JENNIFER
|
DANA-FARBER CANCER INST
|
|
University of Washington/Fred Hutch Center for AIDS Research
|
2P30AI027757-31
|
$508,801
|
$508,801
|
BAETEN, JARED
|
UNIVERSITY OF WASHINGTON
|
|
University of Pittsburgh Multicenter AIDS Cohort Study (MACS)
|
5U01AI035041-26
|
$210,000
|
$210,000
|
RINALDO, CHARLES
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
University of Louisville Cancer Education Program
|
5R25CA134283-07
|
$318,600
|
$318,600
|
HEIN, DAVID
|
UNIVERSITY OF LOUISVILLE
|
|
Understanding the mechanism of action for anticancer sulfonamides that target splicing
|
1R37CA226771-01
|
$366,647
|
$366,647
|
NIJHAWAN, DEEPAK
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
Understanding succinate-induced global transcriptional and epigenetic reprogramming and identifying unique vulnerabilities intrinsic to SDH-deficient cells
|
5F30CA220660-02
|
$44,724
|
$44,724
|
SMESTAD, JOHN
|
MAYO CLINIC ROCHESTER
|
|
Understanding Retroviral Reverse Transcription, Recombination, and Replication
|
ZIA BC 010504
|
$228,049
|
$228,049
|
Hu, Wei-Shau
|
CCR (NCI)
|
|
Understanding Resistance to Next Generation Antiandrogens
|
2R01CA155169-06
|
$386,325
|
$386,325
|
SAWYERS, CHARLES
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Understanding mechanistic role of SAMHD1 in DNA damage response and therapeutic benefit for malignant glioma
|
1K01CA226346-01
|
$109,734
|
$109,734
|
DADDACHA, WAAQO
|
EMORY UNIVERSITY
|
|
Understanding Long Tail Driver Mutations in Cancer
|
5R01CA204749-02
|
$392,078
|
$392,078
|
TAYLOR, BARRY
|
SLOAN-KETTERING INST CAN RESEARCH
|
|
Understanding IDH mutant gliomas
|
ZIA BC 011841
|
$67,687
|
$67,687
|
Wu, Jing
|
CCR (NCI)
|
|
Understanding how adrenergic signaling influences immune contexture of tumors and the efficacy of checkpoint inhibitors
|
1R01CA205246-01A1
|
$576,552
|
$576,552
|
REPASKY, ELIZABETH
|
ROSWELL PARK CANCER INSTITUTE CORP
|
|
Understanding EGF receptor activation by growth factors and oncogenic mutations
|
5R01CA198164-04
|
$520,420
|
$520,420
|
LEMMON, MARK
|
YALE UNIVERSITY
|
Total relevant funding to Cancer for this search: $1,875,883,163
|